The third phase could run concurrently with phase two depending on the availability of vaccines. The Ministry is targeting to vaccinate 4.9 million people during this period.
The vaccines, he says, will be a mix of AstraZeneca, Pfizer, Johnson and Johnson, and any other included in the COVAX facility.
He assured those wary of the vaccines that they have been tested and approved by the Stringent Regulatory Authority (SRA) and are safe for use.
“There are many misconceptions about the Covid-19 vaccines that may lead to vaccination hesitancy. Any adverse effects reported will be investigated and corrective measures are taken up immediately,” he continued.